Organon & Co. (OGN)

USD 11.28

(6.07%)

Operating Expenses Summary of Organon & Co.

  • Organon & Co.'s latest annual operating expenses in 2023 was 2.41 Billion USD , up 11.68% from previous year.
  • Organon & Co.'s latest quarterly operating expenses in 2024 Q1 was 543 Million USD , down -9.95% from previous quarter.
  • Organon & Co. reported a annual operating expenses of 2.17 Billion USD in annual operating expenses 2022, up 3.03% from previous year.
  • Organon & Co. reported a annual operating expenses of 2.11 Billion USD in annual operating expenses 2021, up 7.16% from previous year.
  • Organon & Co. reported a quarterly operating expenses of 553 Million USD for 2024 Q2, up 1.84% from previous quarter.
  • Organon & Co. reported a quarterly operating expenses of 543 Million USD for 2024 Q1, down -9.95% from previous quarter.

Annual Operating Expenses Chart of Organon & Co. (2023 - 2017)

Historical Annual Operating Expenses of Organon & Co. (2023 - 2017)

Year Operating Expenses Operating Expenses Growth
2023 2.41 Billion USD 11.68%
2022 2.17 Billion USD 3.03%
2021 2.11 Billion USD 7.16%
2020 1.97 Billion USD 18.46%
2019 1.66 Billion USD -30.07%
2018 2.37 Billion USD -9.92%
2017 2.64 Billion USD 0.0%

Peer Operating Expenses Comparison of Organon & Co.

Name Operating Expenses Operating Expenses Difference
AbbVie Inc. 24.83 Billion USD 90.26%
Bristol-Myers Squibb Company 34.31 Billion USD 92.95%
Bristol-Myers Squibb Company Ce 34.31 Billion USD 92.95%
Johnson & Johnson 58.6 Billion USD 95.872%
Eli Lilly and Company 16.71 Billion USD 85.529%
Merck & Co., Inc. 43.98 Billion USD 94.501%
Novartis AG 24.87 Billion USD 90.274%
Pfizer Inc. 25.45 Billion USD 90.495%